In a recent announcement, Eric Dane, renowned for his roles in "Euphoria" and "Grey's Anatomy," has disclosed that he has been diagnosed with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative condition. The 52-year-old actor shared his diagnosis with People magazine, highlighting the support of his family during this challenging time. "I feel fortunate that I am able to continue working and am looking forward to returning to set of Euphoria next week," he stated, requesting privacy for himself and his loved ones.
Eric Dane Shares ALS Diagnosis: Actor Vows to Continue Working Amid Health Challenge
Eric Dane Shares ALS Diagnosis: Actor Vows to Continue Working Amid Health Challenge
Actor Eric Dane reveals his ALS diagnosis while expressing gratitude for his family and dedication to his work on "Euphoria."
Dane portrays Cal Jacobs, the father in the Jacobs family on HBO's acclaimed teen drama "Euphoria," which is set to kick off production for its third season shortly. Before his success in "Euphoria," Dane was celebrated for his role as Dr. Mark Sloan in "Grey's Anatomy" and has also starred in series such as "Charmed" and "The Last Ship." He has appeared in popular films like "Marley & Me," "Valentine's Day," and "Burlesque." Dane is married to actress Rebecca Gayheart, and they share two children.
ALS, known as Lou Gehrig's disease, is characterized by the gradual degeneration of motor neurons, which control muscle movements. Symptoms often begin with muscle twitching or weakness in limbs and can progress to affect speech, eating, and breathing. Currently, there is no cure for ALS, with life expectancy averaging three to five years post-diagnosis for most patients, although some may survive longer.
ALS, known as Lou Gehrig's disease, is characterized by the gradual degeneration of motor neurons, which control muscle movements. Symptoms often begin with muscle twitching or weakness in limbs and can progress to affect speech, eating, and breathing. Currently, there is no cure for ALS, with life expectancy averaging three to five years post-diagnosis for most patients, although some may survive longer.
